The purity identification and radiolabeling of α-mangostin with technetium-99m
- PMID: 32154152
- PMCID: PMC7034178
- DOI: 10.4103/japtr.JAPTR_94_19
The purity identification and radiolabeling of α-mangostin with technetium-99m
Abstract
Alpha-mangostin (AM) is a natural compound that has the greatest activity in breast cancer. Radiolabeling AM with technetium-99 m (Tc-99m) has a function as breast cancer radiotracer. This study is aimed to identify the purity of Tc-99m-labeled AM. The identification method was conducted by a validated radio-high-performance liquid chromatography (HPLC) to confirm the chemical purity of the compound when the thin layer of chromatography and paper chromatography were used to find out the radiochemical purity (RCP). The validated radio-HPLC method obtained was C18 column with methanol:water (90:10) as the mobile phase and ultraviolet (243 nm) tandem radioactive detector (Gabi Star). The result showed that the RCP was 70.6% ± 2.87%. The analytical method met the validation criteria according to ICH Q2 (R1); thus, it could be applied in the identification. Unfortunately, the 99mTc-AM identification using radio-HPLC showed that the expected complex was not yet formed perfectly because of chemical impurities.
Keywords: breast cancer; purity identification; 99mTc-alpha-mangostin; radio-high-performance liquid chromatography.
Copyright: © 2020 Journal of Advanced Pharmaceutical Technology & Research.
Conflict of interest statement
There are no conflicts of interest.
Figures





Similar articles
-
Validation of HPLC and TLC analytical methods to determine radiochemical purity of 99mTc-cAbVCAM1-5, a new experimental radiotracer.J Pharm Biomed Anal. 2024 Aug 15;246:116224. doi: 10.1016/j.jpba.2024.116224. Epub 2024 May 14. J Pharm Biomed Anal. 2024. PMID: 38759321
-
Validation of an alternative radiochemical purity method for [99mTc]pentetate ([99mTc]DTPA).Appl Radiat Isot. 2013 Dec;82:322-4. doi: 10.1016/j.apradiso.2013.09.007. Epub 2013 Oct 3. Appl Radiat Isot. 2013. PMID: 24140984
-
Method development, validation, and impurity measurement of β-estradiol from radiolabeled [131I]β-estradiol using radio-high-performance liquid chromatography for radioligand of saturation binding assay.J Adv Pharm Technol Res. 2023 Apr-Jun;14(2):105-112. doi: 10.4103/japtr.japtr_624_22. Epub 2023 Apr 13. J Adv Pharm Technol Res. 2023. PMID: 37255880 Free PMC article.
-
Radio-UHPLC: a tool for rapidly determining the radiochemical purity of technetium-99m radiopharmaceuticals?Appl Radiat Isot. 2013 Aug;78:72-6. doi: 10.1016/j.apradiso.2013.04.005. Epub 2013 Apr 18. Appl Radiat Isot. 2013. PMID: 23681064
-
Validation of HPLC method for the determination of chemical andradiochemical purity of a 68Ga-labelled EuK-Sub-kf-(3-iodo-y-) DOTAGA.Turk J Chem. 2021 Feb 17;45(1):26-34. doi: 10.3906/kim-2003-19. eCollection 2021. Turk J Chem. 2021. PMID: 33679149 Free PMC article.
Cited by
-
Radiosynthesis, Stability, Lipophilicity, and Cellular Uptake Evaluations of [131I]Iodine-α-Mangostin for Breast Cancer Diagnosis and Therapy.Int J Mol Sci. 2023 May 12;24(10):8678. doi: 10.3390/ijms24108678. Int J Mol Sci. 2023. PMID: 37240025 Free PMC article.
-
General toxicity studies of alpha mangostin from Garcinia mangostana: A systematic review.Heliyon. 2023 May 8;9(5):e16045. doi: 10.1016/j.heliyon.2023.e16045. eCollection 2023 May. Heliyon. 2023. PMID: 37215800 Free PMC article.
References
-
- Muchtaridi M, Wijaya CA. Anticancer potential of α-mangostinc. Asian J Pharm Clin Res. 2017;10:440–5.
-
- Won YS, Lee JH, Kwon SJ, Kim JY, Park KH, Lee MK. A-mangostin-induced apoptosis is mediated by estrogen receptor α in human breast cancer cells. Food Chem Toxicol. 2014;66:158–65. - PubMed
-
- Setiawati A, Octa F, Riswanto D, Yuliani S. Anticancer activity of mangosteen pericarp dry extract against mcf-7 breast cancer cell line through estrogen receptor – α. Indones J Pharm. 2014;25:119–24.
-
- Muchtaridi M, Dermawan D, Yusuf M. Molecular docking, 3d structure-based pharmacophore modeling, and adme prediction of α-mangostin and its derivatives against estrogen receptor alpha. J Young Pharm. 2018;10:252.
LinkOut - more resources
Full Text Sources
Miscellaneous